HHS Announces $22 Billion in Funding to Support COVID-19 Testing and Vaccine Distribution

HHS announced two upcoming actions by the CDC to provide more than $22 billion in funding to states, localities, and territories in support of the nation’s response to the COVID-19 pandemic.

Funding will provide critical support for testing and vaccination-related activities to jurisdictions before January 19, 2021:

  • More than $19 billion will be allocated to jurisdictions through the existing CDC Epidemiology and Laboratory Capacity (ELC) cooperative agreement. These awards will support testing, contract tracing, surveillance, containment, and mitigation to monitor and suppress the spread of COVID-19. Award recipients will include 64 jurisdictions including all 50 states, the District of Columbia, five major cities, and U.S. territories/islands. Consistent with Congressional direction, funds will be allocated by a population-based formula.
  • Over $3 billion will be made available in an initial award to jurisdictions through the existing CDC Immunization and Vaccines for Children cooperative agreement. These awards will support a range of COVID-19 vaccination activities across jurisdictions. Award recipients will include 64 jurisdictions including all 50 states, the District of Columbia, five major cities, and U.S. territories/islands. Consistent with Congressional direction, funds will be allocated by a population-based formula.

Funding tables with jurisdictions specific award amounts can be found below. Jurisdictions will be required to comply with terms and conditions of the awards when issued.

Funding for COVID-19 testing – PDF
Funding for vaccination-related activities – PDF

CONTACT US